JPWO2022250108A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022250108A5 JPWO2022250108A5 JP2023524226A JP2023524226A JPWO2022250108A5 JP WO2022250108 A5 JPWO2022250108 A5 JP WO2022250108A5 JP 2023524226 A JP2023524226 A JP 2023524226A JP 2023524226 A JP2023524226 A JP 2023524226A JP WO2022250108 A5 JPWO2022250108 A5 JP WO2022250108A5
- Authority
- JP
- Japan
- Prior art keywords
- alkoxy
- alkyl
- same
- halogen atoms
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021088034 | 2021-05-26 | ||
| PCT/JP2022/021531 WO2022250108A1 (ja) | 2021-05-26 | 2022-05-26 | フェニルウレア誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022250108A1 JPWO2022250108A1 (cg-RX-API-DMAC7.html) | 2022-12-01 |
| JPWO2022250108A5 true JPWO2022250108A5 (cg-RX-API-DMAC7.html) | 2025-06-02 |
Family
ID=84228903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524226A Pending JPWO2022250108A1 (cg-RX-API-DMAC7.html) | 2021-05-26 | 2022-05-26 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240308960A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4353309A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2022250108A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117561238A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022282786A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023024311A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219888A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308659A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023013975A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202313598A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022250108A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| JP7833486B2 (ja) | 2021-05-26 | 2026-03-19 | アルカーメス,インコーポレイテッド | 置換されるカルバメート大環状化合物および関連のある治療方法 |
| CA3248959A1 (en) * | 2022-04-22 | 2025-02-03 | Sumitomo Pharma Co., Ltd. | BICYCLOAMINE CARBOXAMIDE DERIVATIVE |
| WO2025010311A1 (en) * | 2023-07-05 | 2025-01-09 | Vertex Pharmaceuticals Incorporated | Urea-containing agonists of orexin receptor type 2 |
| WO2025010314A1 (en) * | 2023-07-05 | 2025-01-09 | Vertex Pharmaceuticals Incorporated | Urea-containing agonists of orexin receptor type 2 |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1044282A1 (zh) * | 1998-12-18 | 2002-10-18 | Bristol-Myers Squibb Pharma Company | 作为趋化因子受体活性调节剂的n-脲基烷基-哌啶化合物 |
| US6331545B1 (en) * | 1998-12-18 | 2001-12-18 | Soo S. Ko | Heterocycyclic piperidines as modulators of chemokine receptor activity |
| EP1330451B1 (en) * | 2000-10-27 | 2008-01-23 | Ortho-McNeil Pharmaceutical, Inc. | Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| JP4417108B2 (ja) * | 2001-10-15 | 2010-02-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 新規な置換された4−フェニル−4−[1h−イミダゾール−2−イル]−ピペリジン誘導体および選択的非ペプチドデルタオピオイドアゴニストとしてのそれらの使用 |
| AR041992A1 (es) * | 2002-11-06 | 2005-06-08 | Smithkline Beecham Corp | Compuesto de piridinil benzoheterociclico, composicion farmaceutica que lo comprende y su uso para prepararla |
| WO2006007864A1 (en) * | 2004-07-17 | 2006-01-26 | Max Planck Geselllschaft Zur Förderung Der Wissenschaft | Treating neurodegenerative conditions |
| US20090118200A1 (en) * | 2005-05-23 | 2009-05-07 | Bergman Jeffrey M | Proline bis-amide orexin receptor antagonists |
| JP2009506061A (ja) * | 2005-08-26 | 2009-02-12 | メルク エンド カムパニー インコーポレーテッド | ジアザスピロデカンオレキシン受容体拮抗薬 |
| AR062841A1 (es) * | 2006-09-15 | 2008-12-10 | Schering Corp | Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos |
| WO2008098859A1 (en) * | 2007-02-15 | 2008-08-21 | F. Hoffmann-La Roche Ag | Hcv polymerase inhibitors |
| GB0813740D0 (en) * | 2008-07-28 | 2008-09-03 | Angeletti P Ist Richerche Biologica | Therapeutic compounds |
| JP2010155827A (ja) * | 2008-12-04 | 2010-07-15 | Takeda Chem Ind Ltd | スピロ環化合物 |
| JP6346862B2 (ja) * | 2012-02-07 | 2018-06-20 | エオラス セラピューティクス, インコーポレイテッド | オレキシンレセプターアンタゴニストとしての置換プロリン/ピペリジン |
| SG11201806429PA (en) | 2016-02-04 | 2018-08-30 | Takeda Pharmaceuticals Co | Substituted piperidine compound and use thereof |
| US12048703B2 (en) * | 2018-04-13 | 2024-07-30 | University Of North Dakota | Use of small molecule FAK activators to promote mucosal healing |
| WO2022093780A1 (en) * | 2020-10-26 | 2022-05-05 | University Of North Dakota | Use of small molecule fak activators to promote mucosal healing |
-
2022
- 2022-05-26 JP JP2023524226A patent/JPWO2022250108A1/ja active Pending
- 2022-05-26 WO PCT/JP2022/021531 patent/WO2022250108A1/ja not_active Ceased
- 2022-05-26 CA CA3219888A patent/CA3219888A1/en active Pending
- 2022-05-26 AU AU2022282786A patent/AU2022282786A1/en active Pending
- 2022-05-26 IL IL308659A patent/IL308659A/en unknown
- 2022-05-26 MX MX2023013975A patent/MX2023013975A/es unknown
- 2022-05-26 US US18/563,776 patent/US20240308960A1/en active Pending
- 2022-05-26 EP EP22811378.3A patent/EP4353309A4/en active Pending
- 2022-05-26 BR BR112023024311A patent/BR112023024311A2/pt unknown
- 2022-05-26 CN CN202280037665.2A patent/CN117561238A/zh active Pending
- 2022-05-26 TW TW111119648A patent/TW202313598A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019077713A5 (cg-RX-API-DMAC7.html) | ||
| CN103842332B (zh) | 环丙胺化合物 | |
| JP2011517443A5 (cg-RX-API-DMAC7.html) | ||
| JP5215666B2 (ja) | Bay43−9006トシレートの熱力学的に安定な形態 | |
| CO6531470A2 (es) | Derivados benzamida sustituidos | |
| EP2074113A1 (en) | Indazolyl derivatives useful as potassium channel modulating agents | |
| ECSP12012098A (es) | Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos para utilizar los mismos | |
| JP2014528485A5 (cg-RX-API-DMAC7.html) | ||
| JP2010522721A (ja) | プリニル誘導体及びカリウムチャネルモジュレーターとしてのそれらの使用 | |
| RU2009147708A (ru) | Производные оксадиазола и их применение в качестве потенцирующих средств метаботропных глутаматных рецепторов-842 | |
| JP2017528502A5 (cg-RX-API-DMAC7.html) | ||
| JP2010520217A (ja) | ヒスタミンh3受容体のモジュレーターとしてのテトラヒドロイソキノリン化合物 | |
| WO2022250108A1 (ja) | フェニルウレア誘導体 | |
| WO2001060803A1 (en) | Fused imidazolium derivatives | |
| JP2020500869A5 (cg-RX-API-DMAC7.html) | ||
| JP2007500168A5 (cg-RX-API-DMAC7.html) | ||
| RU2006105782A (ru) | Производные 1-сульфонилиндола, их получение и их применение в качестве лигандов 5-нт-6 | |
| JP7071959B2 (ja) | スルホニルピリジルtrp阻害剤 | |
| RU2019120431A (ru) | Производные триазинтриона и их использование в качестве модуляторов нейротрофиновых рецепторов и рецепторов тирозинкиназ | |
| JP2009515934A (ja) | 新規なキナゾリン誘導体及びこれらの医学的使用 | |
| JP6542236B2 (ja) | 有機化合物 | |
| RU2023134503A (ru) | Производное фенилмочевины | |
| JP2011509296A5 (cg-RX-API-DMAC7.html) | ||
| JP2011506391A (ja) | カリウムチャネル活性化因子として有用な、新規の2−エチル−メチル−アミノ−3−アミド−6−アミノ−ピリジン誘導体 | |
| JP2022183120A5 (cg-RX-API-DMAC7.html) |